154 related articles for article (PubMed ID: 7907154)
1. Microinjection of dynorphin into the supraoptic and paraventricular nuclei produces antidiuretic effects through vasopressin release.
Tsushima H; Mori M; Matsuda T
Jpn J Pharmacol; 1993 Dec; 63(4):461-8. PubMed ID: 7907154
[TBL] [Abstract][Full Text] [Related]
2. Microinjections of angiotensin II into the supraoptic and paraventricular nuclei produce potent antidiureses by vasopressin release mediated through adrenergic and angiotensin receptors.
Tsushima H; Mori M; Matsuda T
Jpn J Pharmacol; 1994 Oct; 66(2):241-6. PubMed ID: 7869608
[TBL] [Abstract][Full Text] [Related]
3. Effects of D-Ala2-D-Leu5-enkephalin, microinjected into the supraoptic and paraventricular nuclei, on urine outflow rate.
Tsushima H; Mori M; Matsuda T
Jpn J Pharmacol; 1993 Oct; 63(2):181-6. PubMed ID: 8283828
[TBL] [Abstract][Full Text] [Related]
4. Antidiuretic effects of methionine-enkephalin and 2-D-alanine-5-methionine-enkephalinamide microinjected into the hypothalamic supraoptic and paraventricular nuclei in a water-loaded and ethanol-anesthetized rat.
Tsushima H; Mori M; Matsuda T
Jpn J Pharmacol; 1986 Dec; 42(4):507-15. PubMed ID: 3807052
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
Rochford J; Godin C; Henry JL
Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
[TBL] [Abstract][Full Text] [Related]
6. Antidiuretic effects of morphine microinjected into the hypothalamic supraoptic and paraventricular nuclei in a water-loaded and ethanol-anesthetized rat.
Tsushima H; Mori M; Matsuda T
Jpn J Pharmacol; 1987 Dec; 45(4):449-57. PubMed ID: 3444115
[TBL] [Abstract][Full Text] [Related]
7. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
[TBL] [Abstract][Full Text] [Related]
8. kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo.
Brown CH; Ludwig M; Leng G
J Neurosci; 1998 Nov; 18(22):9480-8. PubMed ID: 9801385
[TBL] [Abstract][Full Text] [Related]
9. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
Vaupel DB; Cone EJ; Johnson RE; Su TP
J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
[TBL] [Abstract][Full Text] [Related]
10. Ionotropic glutamate receptors in hypothalamic paraventricular and supraoptic nuclei mediate vasopressin and oxytocin release in unanesthetized rats.
Busnardo C; Crestani CC; Resstel LB; Tavares RF; Antunes-Rodrigues J; Corrêa FM
Endocrinology; 2012 May; 153(5):2323-31. PubMed ID: 22396452
[TBL] [Abstract][Full Text] [Related]
11. Central regulation of urine production by a selective mu-opioid agonist, [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin, in rats.
Tsushima H; Mori M; Matsuda T
Jpn J Pharmacol; 1997 May; 74(1):45-9. PubMed ID: 9195296
[TBL] [Abstract][Full Text] [Related]
12. Effect of vasopressin antagonist on antidiuresis by oxotremorine microinjected into the hypothalamic supraoptic and paraventricular nuclei in a water-loaded and ethanol-anesthetized rat.
Mori M; Tsushima H; Matsuda T
Jpn J Pharmacol; 1989 Mar; 49(3):357-64. PubMed ID: 2747038
[TBL] [Abstract][Full Text] [Related]
13. In vivo modulation of post-spike excitability in vasopressin cells by kappa-opioid receptor activation.
Brown CH; Leng G
J Neuroendocrinol; 2000 Aug; 12(8):711-4. PubMed ID: 10929081
[TBL] [Abstract][Full Text] [Related]
14. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR
J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735
[TBL] [Abstract][Full Text] [Related]
15. Peptidase inhibitor-induced antidiuresis mediated through angiotensin and opioid receptors in the rat hypothalamus.
Tsushima H; Mori M; Matsuda T
Jpn J Pharmacol; 1996 May; 71(1):61-71. PubMed ID: 8791172
[TBL] [Abstract][Full Text] [Related]
16. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
Madamba SG; Schweitzer P; Siggins GR
J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
[TBL] [Abstract][Full Text] [Related]
17. Antidiuretic effects of oxotremorine microinjected into the hypothalamic supraoptic and paraventricular nuclei in a water-loaded and ethanol-anesthetized rat.
Mori M; Tsushima H; Matsuda T
Jpn J Pharmacol; 1984 May; 35(1):27-36. PubMed ID: 6471618
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures.
Kong LY; McMillian MK; Hudson PM; Jin L; Hong JS
J Pharmacol Exp Ther; 1997 Jan; 280(1):61-6. PubMed ID: 8996182
[TBL] [Abstract][Full Text] [Related]
19. Comparison with naloxone of two dynorphin A analogues with K- and delta-opioid antagonist activity.
Capasso A
Med Chem; 2009 Jan; 5(1):1-6. PubMed ID: 19149644
[TBL] [Abstract][Full Text] [Related]
20. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
